Effect of Terfenadine and Pentamidine on the hERG Channel and Its Intracellular Trafficking: Combined Analysis with Automated Voltage Clamp and Confocal Microscopy-Reference-Cited by-同舟云学术

Effect of Terfenadine and Pentamidine on the hERG Channel and Its Intracellular Trafficking: Combined Analysis with Automated Voltage Clamp and Confocal Microscopy

Published:2014 Issue:11 Volume:37 Page:1826-1830
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Tanaka Hikaru¹,Takahashi Yukiko¹,Hamaguchi Shogo¹,Iida-Tanaka Naoko²,Oka Takayuki¹,Nishio Masato¹,Ohtsuki Atsushi¹,Namekata Iyuki¹

Affiliation:

1. Department of Pharmacology, Toho University Faculty of Pharmaceutical Sciences

2. Department of Food Science, Otsuma Women’s University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/37/11/37_b14-00417/_pdf

Reference28 articles.

1. 1) Tamargo J. Drug-induced torsade de pointes: from molecular biology to bedside. Jpn. J. Pharmacol., 83, 1–19 (2000).

2. 2) Hashimoto K. Arrhythmia models for drug research: classification of antiarrhythmic drugs. J. Pharmacol. Sci., 103, 333–346 (2007).

3. 3) Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat. Rev. Drug Discov., 2, 439–447 (2003).

4. 4) Salata JJ, Jurkiewicz N, Wallace A, Stupienski R 3rd, Guinosso P Jr, Lynch J Jr. Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ. Res., 76, 110–119 (1995).

5. 5) Bran S, Murray W, Hirsch I, Palmer J. Long QT syndrome during high-dose cisapride. Arch. Intern. Med., 155, 765–768 (1995).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensemble of structure and ligand-based classification models for hERG liability profiling;Frontiers in Pharmacology;2023-03-23

2. Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators;Pharmacokinetics and Pharmacodynamics;2023-01-18

3. Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning techniques;Frontiers in Pharmacology;2022-09-05

4. Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether‐à‐go‐go–Related Gene and Cav1.2;Frontiers in Pharmacology;2022-07-07

5. High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition;Biology;2022-01-28